Newsfeeds - Spark Newswire

1 minute read

Uncategorized

Aurinia Pharma’s Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet

Today, 6:40 AM

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced that The Lancet published its Phase 3 AURORA 1 study evaluating Lupkynis (voclosporin) in adults…

AUPH

5 minute read

Uncategorized

70 Biggest Movers From Friday

By Lisa Levin

Today, 6:40 AM

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.

ADTN

1 minute read

Uncategorized

Cramer Shares His Thoughts On Atkore, Petco And More

By Craig Jones

Today, 6:40 AM

On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers American Electric Power Company Inc (NASDAQ: AEP) over Consolidated Edison, Inc. (N

AEP

32 minute read

Uncategorized

Earnings Scheduled For May 6, 2021

By Benzinga Insights

Today, 6:40 AM

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.

AAOI

8 minute read

Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline

Today, 6:40 AM

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS

1 minute read

Uncategorized

Aurinia Pharma Stock Showing A Potential Reversal Pattern: 4 Key Levels To Watch

By Tyler Bundy

Today, 6:40 AM

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was trending Tuesday afternoon possibly amid the stock making a new 52-week low. Below are the technical levels to watch on the chart. Aurinia Daily Chart Analysis:

AUPH